# BOTOX® in the Treatment of Crow's Feet Lines in China

> **NCT02195687** · PHASE3 · COMPLETED · sponsor: **Allergan** · enrollment: 417 (actual)

## Conditions studied

- Lateral Canthal Lines
- Crow's Feet Lines

## Interventions

- **BIOLOGICAL:** botulinum toxin Type A
- **DRUG:** Normal Saline

## Key facts

- **NCT ID:** NCT02195687
- **Lead sponsor:** Allergan
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-09
- **Primary completion:** 2015-02
- **Final completion:** 2015-06
- **Target enrollment:** 417 (ACTUAL)
- **Last updated:** 2016-03-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02195687

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02195687, "BOTOX® in the Treatment of Crow's Feet Lines in China". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02195687. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*